🔗 Share this article

Chancellor Rachel Reeves has stated she is preparing "focused measures to tackle cost of living pressures" in next month's Budget.

During an interview with media outlets, she emphasized that reducing inflation is a collective responsibility of both the administration and the central bank.

The United Kingdom's price growth is projected to be the highest among the Group of Seven developed nations this year and next.

Potential Utility Cost Measures

It is understood the government could intervene to lower energy bills, for example by reducing the current 5% rate of value-added tax applied on energy.

Another possibility is to cut some of the policy costs currently added to bills.

Fiscal Limitations and Expert Expectations

The administration will receive the latest report from the independent fiscal watchdog, the OBR, on Monday, which will clarify how much room there is for such measures.

The expectation from the majority of analysts is that the Chancellor will have to announce higher taxes or budget cuts in order to meet her declared debt limits.

Earlier on Thursday, analysis suggested there was a twenty-two billion pound deficit for the chancellor to resolve, which is at the more modest range of expectations.

"There's a shared task between the central bank and the administration to continue tackling some of the sources of price increases," the Chancellor told the BBC in Washington, at the conferences of the International Monetary Fund and World Bank.

Tax Pledges and Global Issues

While much of the focus has been on likely tax rises, the Treasury chief said the most recent data from the fiscal watchdog had not changed her vow to manifesto promises not to raise rates on earnings tax, VAT or National Insurance.

She blamed an "unpredictable global environment" with growing international and trade tensions for the fiscal tax moves, probably to be directed on those "with the broadest shoulders."

Global Trade Disputes

Commenting on apprehensions about the UK's trade ties with the Asian nation she said: "Our national security always are paramount."

Last week's declaration by Chinese authorities to strengthen trade restrictions on rare earths and other materials that are essential for high-technology manufacturing led American leader the US President to threaten an further 100% import tax on goods from the Asian country, increasing the risk of an full-scale trade war between the two largest economies.

The US Treasury Secretary labeled the Chinese action "economic coercion" and "a global supply chain control attempt."

Inquired about accepting the American proposal to join its battle with the Asian nation, Reeves said she was "extremely troubled" by Chinese actions and encouraged the Beijing authorities "to avoid restrictions and restrict access."

She said the decision was "harmful for the international commerce and generates additional headwinds."

"It is my opinion there are fields where we must address Chinese policies, but there are also significant opportunities to export to China's economy, including financial services and other sectors of the economic system. We've got to get that equilibrium correct."

The Treasury chief also affirmed she was cooperating with other major economies "on our own critical minerals approach, so that we are less reliant."

NHS Medicine Costs and Funding

Reeves also recognized that the price the National Health Service spends on medicines could go up as a consequence of current negotiations with the Trump administration and its pharmaceutical firms, in exchange for reduced taxes and investment.

Some of the biggest global drug companies have said in recent statements that they are either pausing or canceling investments in the United Kingdom, with several attributing the insufficient payments they are receiving.

Recently, the government science advisor said the cost the health service spends on drugs would have to rise to prevent firms and drug research funding departing from the United Kingdom.

The Chancellor informed media: "We have seen due to the pricing regime, that drug testing, recent pharmaceuticals have not been provided in the United Kingdom in the manner that they are in other continental states."

"We want to ensure that individuals receiving care from the NHS are able to receive the best essential treatments in the world. And so we are examining these issues, and... looking to attract more funding into the UK."